KAUST researchers introduce deepBlastoid, an AI platform automating and standardizing classification of human blastoids from brightfield images with high accuracy and efficiency.
Key Details
- 1deepBlastoid uses a ResNet-18 architecture to classify human blastoid images in five categories.
- 2The curated dataset includes 17,133 brightfield images, with 2,407 expert-labeled.
- 3Achieved up to 97% accuracy by combining the base model (87%) with a Confidence Rate metric for expert fallback.
- 4Processes 273.6 images per second—1,000 times faster than human experts.
- 5Tool validated in drug dose optimization and safety assessment use cases.
- 6Publicly available tools and dataset support global research customization.
Why It Matters
DeepBlastoid exemplifies the potential of AI-powered image analysis for scalable, objective, and reproducible evaluation in developmental biology—a workflow parallel to emerging radiology and digital pathology automation. Its open-source tools may inspire similar strategies for image-intensive tasks in radiology and pathology.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.